ArchiveMay 2016

CrowdSpeak: blog administrator & charity

How do you feel about supporting the Barts-MS Blog via crowd-funding? #CrowdSpeak #MSBlog #MSResearch “As part of our efforts to find, and redefine, our mojo and evolve the blog it has become clear that we need a blog administrator to lessen our work load and to support all the planned activities going forward. This is particularly important for managing the guest posts and to handle...

Chronic pain – Wile E. Cyote style

Chronic pain disrupts the reward circuitry in multiple sclerosis Daniela Seixas, Jacqueline Palace and Irene Tracey. European Journal of Neuroscience. DOI: 10.1111/ejn.13272. Abstract Pain commonly affects multiple sclerosis (MS) patients, and has the potential to become chronic and burden an already damaged central nervous system. Imaging studies are providing insights into brain restructuring...

Is failure of an arm of MS SMART on the cards?

Zhang T, Kingwell E, De Jong HJ, Zhu F, Zhao Y, Carruthers R, Petkau J, Gustafson P, Oger J, Tremlett H. Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression. Pharmacoepidemiol Drug Saf. 2016 May 23. doi: 10.1002/pds.4031. [Epub ahead of print] BACKGROUND:Benefits of selective serotonin reuptake inhibitors (SSRIs) in modifying the...

ClinicSpeak: intermittent fasting

Will intermittent fasting turnout to be an effective DMT? #ClinicSpeak #MSBlog #MSRsearch “One of our readers pointed me to the paper below on the apparent health benefits of fasting. The animal study suggests fasting promotes resistance to stress and possibly increased life span. They showed that alternating fasting with feasting extended the lifespan of yeast independently of established...

NewsSpeak: FDA approves daclizumab

Another milestone for daclizumab in the treatment of relapsing forms of MS. #MSBlog #MSResearch #NewsSpeak “The FDA has approved daclizumab (Zinbryta) for the treatment of relapsing forms of MS. However, the FDA have recommended it be used second or third line, presumably because of its safety profile and need for monitoring. The US label is very different to the recommendation of the CHMP...

Drugs Studies from the AAN

ProfG on CLAD and why he thinks it will come back Clinical efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis (RRMS): final results from the 120-week phase IIIb extension trial to the CLARITY study (Poster 3.028). Authors: Gavin Giovannoni, Giancarlo Comi, Stuart Cook, Peter Rieckmann, Kottil Rammohan, Per Soelberg-Sorensen, Patrick Vermersch, E. Martin and...

CongressSpeak & BrainHealh: European Neurological Association Meeting 2016 – Copenhagen

I am trying not to neglect my own brain health, but it is difficult. #CongressSpeak #ENA2016 #BrainHealth #MSBlog “I am not a happy bunny; I am about to spend another weekend working, including bank holiday Monday. Monday is a holiday in the UK; it is called a bank holiday because the banks are closed. I had to get-up at 6am this morning to pack and travel to Copenhagen (still in transit)...

SurveySpeak: routine cognitive testing

Wow MSers want routine annual cognitive testing. #SurveySpeak #MSBlog #MSResearch “The following are the results of yesterday’s survey. It is clear that the majority of you want to be offered cognitive testing. Professor Dawn Langdon will be happy. Regular cognitive testing may bring one of the hidden problems of MS out into the open and reinforce the observation that MS is a...

Saving Animals is the name of the game, but is the Masterchef approach to Science going to be Counterproductive

Prof B presented at this weeks nights “Pint of Science ”  offering in London in the Beautiful Mind section It was nothing to do with potatoes as shown in the advert above. but a Journey of Discovery that started with an unlikely observation in a Beetle (Cow pea weevil) and ended in MS. ProfB presented the group’s lastest findings in MS to a public audience. He asked...

ResearchSpeak: reflections on the ABN

My pod-casting experiment from the ABN #ResearchSpeak #ABN2016 #MSBlog  I spent most of last week at the annual Association of British Neurologists (ABN) meeting in Brighton. I chaired two debates, presented 4 posters and was co-presenter on another 2 posters. I also networked and met many young neurologists and saw some old friends. The debates: Debate 1: ‘Was the NICE mandate that pwMS...

Translate

Categories

Recent Posts

Recent Comments

Archives